The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
A Randomized Comparison of Two Ovarian Stimulation Protocols with Gonadotropin-Releasing Hormone (GnRH) Antagonist Cotreatment for in Vitro Fertilization Commencing Recombinant Follicle-Stimulating Hormone on Cycle Day 2 or 5 with the Standard Long GnRH Agonist Protocol
Open accessAbstract
Extending the FSH window for multifollicular development by administering FSH from the midfollicular phase onward constitutes a novel mild protocol for ovarian stimulation for in vitro fertilization (IVF) based on the physiology of single dominant follicle selection in normo-ovulatory women. We compared outcomes from this protocol with two other stimulation protocols. One hundred and forty-two normo-ovulatory patients with an indication for IVF (or IVF/ICSI) were randomized to a GnRH agonist long protocol (group A; n = 45) or one of two GnRH antagonist protocols commencing recombinant FSH on cycle d 2 (group B; n = 48) or cycle d 5 (group C; n = 49). A fixed dose (150 IU/d) of rFSH was used for ovarian stimulation, and GnRH antagonist cotreatment was initiated on the day when the leading follicle reached 14 mm diameter. Group C showed a shorter duration of stimulation (median duration, 11, 9, and 8 d for groups A, B, and C, respectively; P < 0.001), reflected in a significantly lower total dose of rFSH used (median amount of rFSH, 1650, 1350, and 1200 IU for groups A, B, and C, respectively; P < 0.001). In group C more cycles were cancelled during the stimulation phase due to insufficient response, resulting in a lower percentage of oocyte retrievals (84%, 73%, and 63% for groups A, B, and C; P = 0.02). However, women in group C obtained better quality embryos (percentage of embryo score of 1 for best embryo, 29%, 37%, and 61% for groups A, B, and C, respectively; P = 0.008), resulting in more transfers per oocyte retrieval (68%, 71%, and 90% for groups A, B, and C, respectively; P = 0.04). After profound ovarian stimulation (groups A and B) only 7% of the patients who retrieved four oocytes or less conceived, whereas after mild stimulation (group C) 67% of these patients conceived (P < 0.01). Overall, no differences were found among the three groups comparing pregnancy rate per started IVF cycle. In conclusion, application of the described mild ovarian stimulation protocol resulted in pregnancy rates per started IVF cycle similar to those observed after profound stimulation with GnRH agonist cotreatment despite shorter stimulation and a 27% reduction in exogenous FSH. A higher cancellation rate before oocyte retrieval was compensated by improved embryo quality concomitant with a higher chance of undergoing embryo transfer. A relatively low number of oocytes retrieved after mild ovarian stimulation distinctly differs from the pathological reduction in the number of oocytes retrieved after profound ovarian stimulation (poor response) associated with poor IVF outcome. The relatively small number of oocytes obtained after mild ovarian stimulation may represent the best of the cohort in a given cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of dimeric inhibin B throughout the human menstrual cycle
Groome, N. P. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.4.1401 · Cited by 946
Factors that affect outcome of in-vitro fertilisation treatment
Templeton, A., Morris, J. K., & Parslow, W. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05291-9 · Cited by 708
Assisted reproductive technology
Silva, S. G. D., Bertoldi, A. D., Silveira, M. F. D., Domingues, M. R., Evenson, K. R., & Santos, I. S. D. (2019) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2019053000737 · Cited by 513
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences*
Fauser, B. C. J. M., & van Heusden, A. M. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0290 · Cited by 509
Self-citationGerris, J., De Neubourg, D., Mangelschots, K., Van Royen, E., Van de Meerssche, M., & Valkenburg, M. (1999) · Human Reproduction · doi:10.1093/humrep/14.10.2581 · Cited by 417
Reducing the Risk of Multiple Births by Transfer of Two Embryos after in Vitro Fertilization
Templeton, A., & Morris, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390901 · Cited by 391
The European Orgalutran® Study Group, Borm, G., & Mannaerts, B. (2000) · Human Reproduction · doi:10.1093/humrep/15.7.1490 · Cited by 376
Clinical management of low ovarian response to stimulation for IVF: a systematic review
Tarlatzis, B. C. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg007 · Cited by 365
One versus two embryo transfer after IVF and ICSI: a randomized study
Martikainen, H., Tiitinen, A., Tomás, C., Tapanainen, J., Orava, M., Tuomivaara, L., Vilska, S., Hydén-Granskog, C., & Hovatta, O. (2001) · Human Reproduction · doi:10.1093/humrep/16.9.1900 · Cited by 351
GnRH antagonist in assisted reproduction: a Cochrane review
Al-Inany, H. (2002) · Human Reproduction · doi:10.1093/humrep/17.4.874 · Cited by 345
Cited by
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
Infertility and the provision of infertility medical services in developing countries
Ombelet, W., Cooke, I., Dyer, S., Serour, G., & Devroey, P. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn042 · Cited by 720
Baart, E. B., Martini, E., Eijkemans, M. J., Van Opstal, D., Beckers, N. G. M., Verhoeff, A., Macklon, N. S., & Fauser, B. C. J. M. (2007) · Human Reproduction · doi:10.1093/humrep/del484 · Cited by 609
Self-citationGonadotrophin-releasing hormone antagonists for assisted reproductive technology
Al-Inany, H. G., Youssef, M. A., Ayeleke, R. O., Brown, J., Lam, W. S., & Broekmans, F. J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001750.pub4 · Cited by 600
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Macklon, N. S., Stouffer, R. L., Giudice, L. C., & Fauser, B. C. J. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0015 · Cited by 562
Self-citationESHRE guideline: ovarian stimulation for IVF/ICSI†
The ESHRE Guideline Group on Ovarian Stimulation, Bosch, E., Broer, S., Griesinger, G., Grynberg, M., Humaidan, P., Kolibianakis, E., Kunicki, M., La Marca, A., Lainas, G., et al. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa009 · Cited by 543
Multiple birth resulting from ovarian stimulation for subfertility treatment
Fauser, B. C., Devroey, P., & Macklon, N. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66478-1 · Cited by 407
Self-citationLambalk, C. B., Banga, F. R., Huirne, J. A., Toftager, M., Pinborg, A., Homburg, R., van der Veen, F., & van Wely, M. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx017 · Cited by 404
The role of the endometrium and embryo in human implantation
Diedrich, K., Fauser, B. C. J. M., Devroey, P., & Griesinger, G. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm011 · Cited by 354
Self-citationA mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial
Heijnen, E. M., Eijkemans, M. J., De Klerk, C., Polinder, S., Beckers, N. G., Klinkert, E. R., Broekmans, F. J., Passchier, J., Te Velde, E. R., Macklon, N. S., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60360-2 · Cited by 349
Self-citationPreventing ovarian hyperstimulation syndrome: guidance for the clinician
Humaidan, P., Quartarolo, J., & Papanikolaou, E. G. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.028 · Cited by 321
Baart, E. B., Martini, E., van den Berg, I., Macklon, N. S., Galjaard, R.-J. H., Fauser, B. C. J. M., & Van Opstal, D. (2006) · Human Reproduction · doi:10.1093/humrep/dei291 · Cited by 312
Self-citationBeckers, N. G. M., Macklon, N. S., Eijkemans, M. J., Ludwig, M., Felberbaum, R. E., Diedrich, K., Bustion, S., Loumaye, E., & Fauser, B. C. J. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021953 · Cited by 307
Self-citationKolibianakis, E. M., Collins, J., Tarlatzis, B. C., Devroey, P., Diedrich, K., & Griesinger, G. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml038 · Cited by 306
Hart, R., & Norman, R. J. (2013) · Human Reproduction Update · doi:10.1093/humupd/dms062 · Cited by 266
Affordable IVF for developing countries
Ombelet, W., & Campo, R. (2007) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60337-9 · Cited by 107
Wiegel, R. E., Danser, A. H. J., van Duijn, L., Willemsen, S. P., Laven, J. S. E., Steegers, E. A. P., Baart, E. B., & Steegers-Theunissen, R. P. M. (2023) · Human Reproduction · doi:10.1093/humrep/dead030 · Cited by 8
Metadata
- Authors
- Hohmann, F. P., Macklon, N. S., & Fauser, B. C. J. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-01
- Volume
- 88
- Issue
- 1
- Pages
- 166-173
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2128878511
- Cited by
- 281
- References
- 34
- FWCI
- 15.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.